Although the combined sensitivity of PRL for MS/CIS was 24.0% (CI = 18.9%–29.8%), PRLs had a very high specificity of 99.7% (CI = 98.2%–99.99%) and a PPV (positive predictive value) of 98.39. The gene discussed is PRL; the disease is myeloid sarcoma.